Skip to content

Clinical trials

Completed Carcinoma, Non-Small-Cell Lung trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Completed Country / region: Serbia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20061
20081
20101
20113
20121
20143
20152
20164
20183
20192
20203
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
Boehringer Ingelheim3
Helsinn Therapeutics (U.S.), Inc2
NovoCure GmbH2
AbbVie1
AstraZeneca1
Cellectar Biosciences, Inc.1
Centus Biotherapeutics Limited1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung27
Cachexia3
Lung Neoplasms2
Neoplasm Metastasis2
Neoplasms2
Adenocarcinoma of Lung1
Brain Neoplasms1
Pericardial Effusion1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.